Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. - Wikidata - awgldk - TriplyDB

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.

http://www.wikidata.org/entity/Q39309227

about

Sublingual immunotherapy for asthma Sublingual immunotherapy for allergic rhinitis How does the efficacy and safety of Oralair(®) compare to other products on the market?Sublingual immunotherapy for pediatric allergic rhinitis: The clinical evidence Critical appraisal of Timothy grass pollen extract GRAZAX in the management of allergic rhinitis.New treatments for allergen immunotherapy Sublingual immunotherapy: World Allergy Organization position paper 2013 update.Sublingual immunotherapy in children with allergic rhinitis: quality of systematic reviews.Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax(®)) in children Strategies of mucosal immunotherapy for allergic diseases A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocol.SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma.Sublingual immunotherapy in children: facts and needs.Diseases of the nose and paranasal sinuses in child.Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure The need for patient-focused therapy for children and teenagers with allergic rhinitis: a case-based review of current European practice Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Asso Subtropical grass pollen allergens are important for allergic respiratory diseases in subtropical regions.Tolerability of the SQ-standardised grass sublingual immunotherapy tablet in patients treated with concomitant allergy immunotherapy: a non-interventional observational study.Allergen immunotherapy for allergic respiratory diseases The efficacy assessment of a self-administered immunotherapy protocol A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma.Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study.Safety and tolerability of an intra-seasonal initiation of the SQ-standardised grass allergy immunotherapy tablet: a non-interventional observational study investigating the feasibility during routine administration.A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study.Clinical management, expectations, and satisfaction of patients with moderate to severe allergic rhinoconjunctivitis treated with SQ-standardized grass-allergen tablet under routine clinical practice conditions in Spain Investigational drugs for allergic rhinitis.Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report Emerging sublingual immunotherapy drugs.Clinical practice: Allergen-specific immunotherapy in children: facts and FAQs.Specific immunotherapy in asthma: efficacy and safety.Systematic reviews of sublingual immunotherapy (SLIT).How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.Specific immunotherapy in children.Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.A national audit of pollen immunotherapy for children in the United Kingdom: patient selection and programme safety.Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta-analysis.Asthma in children and adolescents: a comprehensive approach to diagnosis and management.Regulatory cells in allergen-specific immunotherapy.

P2860

Q24187736-16DE5154-F045-4189-BAA0-EF4F1A40E891 Q24235551-95BC8CA1-3E34-4098-83DA-38244F23F32C Q26745596-7F590508-8ADD-44D6-B844-AF7BA15D5592 Q26767010-F30885A1-336B-4C3A-BC3C-1E347D25744C Q26775905-7E6C5A13-C63E-435C-8E84-1B7D066A24B1 Q27016089-9B6ECC74-E08D-46CA-A3E1-944BA5EF36E0 Q30440195-AB7CC666-9074-4BA5-98E1-EE6BF87A9EE9 Q31030974-CD4551FA-D8D7-43AE-AA64-28C0B335CB19 Q33573199-24256EBC-D326-4C71-9009-B4C1FEDBE9C7 Q33577679-FA9C117B-E92E-4CEF-93AB-9CFE6333CE75 Q33914193-6B4223EE-3126-4795-A3C6-2772AA49F737 Q34548671-FFFAD09B-CB19-42CC-8D98-C3479391F299 Q34577305-330BE6D3-55F6-4470-812C-BC77559B1010 Q34613104-56198F98-8D99-42F0-B0B3-0F7143F695E3 Q34751071-011B0B71-4343-4A65-A52B-9A71F1A9715F Q35040990-8AAA3E2A-A8BB-42DD-BBC2-EF0DF726D20A Q35052674-FC36E02D-1227-4FE5-B785-21761BCA934E Q35777126-F75729C2-D700-4A97-9120-4F73A515DFF0 Q35873490-9B3E9601-4158-42DB-9088-DA714FC205DA Q36662274-C4C7B55A-5F0D-425C-B307-2D41414D3F6A Q36864947-B37A2F0C-D988-4751-BD0E-AE8C521026E8 Q36881918-68A53747-DB31-4A03-A2AF-5EF61579C5BB Q36945591-5D156A41-C55D-4B05-89ED-CA6CE1DF0757 Q36963993-B66E0754-C106-408B-BD16-903058F8F4B9 Q37177099-9CC5B466-9F10-4222-94EF-27D2334A2689 Q37325838-B9F14146-AED7-4B6D-ABB1-E78D168719D7 Q37584828-8D079734-13A0-4E0E-B9AA-93150469212A Q37650382-CC576557-FEB2-40B2-869E-BB88D8985094 Q37696401-390832F9-98C9-4AD2-8550-5A3AB297DEFF Q37801372-FD2D4F2C-B626-424A-A666-E0B36612643D Q37820336-7510D1FD-485E-41AA-B569-13C979F54486 Q37831393-19D91251-37C8-45DE-A99D-6830402AD647 Q37858626-955D7A23-2A58-43BD-A44C-55813D8E7388 Q37865584-E21AF976-6E30-4AA0-87E3-9D81050851FE Q37868712-601BD07E-E735-4C1E-BF1A-2640BB91AAA4 Q37888684-0D2030E4-147C-4B81-891C-E9D6C782D8CC Q37901535-34FFD9D6-197B-43FD-BBC2-C7654059F3DD Q37919134-8B4363A4-1453-437E-8FE0-C61FDA8CEC92 Q37970318-95F00F33-8905-4C74-AB0C-0FF3FCBE79C6 Q38003474-76E035B6-CD75-41FC-B3D4-7A826A372062

P2860

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.

http://www.wikidata.org/entity/Q39309227

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Safety and efficacy in childre ...... for sublingual immunotherapy.

@en

Safety and efficacy in childre ...... for sublingual immunotherapy.

@nl

type

label

Safety and efficacy in childre ...... for sublingual immunotherapy.

@en

Safety and efficacy in childre ...... for sublingual immunotherapy.

@nl

prefLabel

Safety and efficacy in childre ...... for sublingual immunotherapy.

@en

Safety and efficacy in childre ...... for sublingual immunotherapy.

@nl

P1433

Q39309227-F669003B-8C63-4BB2-BE09-ABC23CCB9B4E

P1476

Q39309227-98CE6D07-9DF7-4DA7-AD0B-6AFC25C569A0

P2093

Q39309227-05C8D2AE-80E6-49A9-8FB8-C88325193DA4

Q39309227-3271D8F1-0C1E-4F36-A686-5690B738F24F

Q39309227-47AB034A-4DC2-43AE-AEBF-25C9148E13D2

Q39309227-4D93D54F-6E3E-4293-9D89-AFEC3C0AEA4A

Q39309227-799EABED-416F-462F-B680-BC33176CD471

Q39309227-92319A98-F379-482E-AC20-AD6FF01A04D7

Q39309227-A3A193CD-7E6A-4A38-8833-5A23D29B6472

Q39309227-E0D973A0-243A-4804-88DE-3624689513DF

Q39309227-F257C8FC-8AEF-4CCF-BFD6-6FFA9742C9DB

Q39309227-FF7C55DA-FD0E-4291-8A71-54DEC0A2D711

P304

Q39309227-369748CB-623B-4601-87B3-5748E4288AE4

P31

Q39309227-A5B27CD8-AC93-40DB-8686-8D624EE1A286

P356

Q39309227-AC30971E-74FD-4946-AB2F-91F40C7DED6E

P407

Q39309227-9A2EA89B-6347-4E4B-BE0C-3133E76667D1

P433

Q39309227-81FB32F4-1027-4E78-936F-AA1E934FF8F9

P478

Q39309227-596CFA58-FD36-4802-B865-743345AF348C

P50

Q39309227-C1B16AB9-CF7C-4D70-875E-4AC7C570B515

P577

Q39309227-4EF99ACB-A018-4AA1-8C92-A3A9133A6D18

P5875

Q39309227-DC35CF43-FD33-423F-B18F-B58DDA9F4908

P698

Q39309227-2E9DA7F9-DC3D-4850-8863-39E3C1DB72B9

P921

Q39309227-37E4DADE-C6E7-4EBC-B40D-A2BC8CBBB240

P356

J.JACI.2008.10.044

P1433

The Journal of Allergy and Clinical Immunology

P1476

Safety and efficacy in childre ...... for sublingual immunotherapy.

@en

P2093

Bente Tholstrup

http://www.w3.org/2001/XMLSchema#string

Christian Weisshaar

http://www.w3.org/2001/XMLSchema#string

Eivy Franke-Beckmann

http://www.w3.org/2001/XMLSchema#string

Friedrich Kaiser

http://www.w3.org/2001/XMLSchema#string

Jürgen Funck

http://www.w3.org/2001/XMLSchema#string

Ludger Klimek

http://www.w3.org/2001/XMLSchema#string

Martin Kimmig

http://www.w3.org/2001/XMLSchema#string

Peter Eberle

http://www.w3.org/2001/XMLSchema#string

Roland Knecht

http://www.w3.org/2001/XMLSchema#string

Volker Stephan

http://www.w3.org/2001/XMLSchema#string

P304

167-173.e7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2008.10.044

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23765722

http://www.w3.org/2001/XMLSchema#string

P698

19130937

http://www.w3.org/2001/XMLSchema#string

P921